Glioma Panel (MGMT, IDH1&2, FISH 1p19q)
The Glioma Panel (MGMT, IDH1&2, FISH 1p19q) is a specialized diagnostic test that plays a pivotal role in the management of gliomas, a type of brain tumor. This test is designed to analyze critical genetic mutations that can influence treatment decisions and prognostic outcomes for patients suffering from gliomas.
Importance of the Glioma Panel Test
Understanding the genetic makeup of gliomas is essential for tailoring effective treatment strategies. The Glioma Panel test provides comprehensive insights into the presence of specific mutations, enabling oncologists to make informed decisions about the most appropriate therapies.
What the Test Measures
- MGMT Methylation Status: Evaluates the methylation of the MGMT gene, which can predict the response to certain chemotherapy agents.
- IDH1 and IDH2 Mutations: Identifies mutations in the IDH1 and IDH2 genes that are associated with glioma development.
- FISH 1p19q Co-deletion: Detects the co-deletion of chromosomal regions 1p and 19q, which is a significant prognostic indicator in glioma patients.
Who Should Consider This Test?
This test is recommended for patients diagnosed with gliomas or those who exhibit symptoms such as:
- Persistent headaches
- Seizures
- Changes in cognitive function or personality
- Neurological deficits
Individuals with a family history of brain tumors or genetic predispositions may also benefit from this test.
Benefits of Taking the Test
- Informs treatment planning and personalized therapy options.
- Helps predict patient prognosis and potential outcomes.
- Guides the use of targeted therapies and clinical trial eligibility.
Understanding Your Results
Results from the Glioma Panel test will provide insight into the genetic alterations present in the tumor. Oncologists will interpret these results to recommend the most effective treatment plan tailored to the patient’s specific genetic profile.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Glioma Panel (MGMT, IDH1&2, FISH 1p19q) | 720,000 NGN | 960,000 NGN |
Booking Your Test
To book the Glioma Panel test, please contact us at +2348077798758. Our team is ready to assist you with the booking process and provide any additional information you may need.
Turnaround Time and Sample Type
The test has a turnaround time of approximately 2-3 weeks and requires a sample of tumor tissue for analysis. Please note that this test can only be conducted with a doctor’s prescription, which is not applicable for surgery or pregnancy cases, or for individuals planning to travel abroad.
Take proactive steps towards your health by understanding your glioma diagnosis. Book your Glioma Panel (MGMT, IDH1&2, FISH 1p19q) test today!
